Skip to content
Skip to main content

About this free course

Author

Download this course

Share this free course

COVID-19: Immunology, vaccines and epidemiology
COVID-19: Immunology, vaccines and epidemiology

Start this free course now. Just create an account and sign in. Enrol and complete the course for a free statement of participation or digital badge if available.

1.3 Mutation in the spike protein

As noted previously, mutations tend to cluster in the gene encoding the spike protein, but even there they are not evenly distributed. For example compared with the original Wuhan strain, Omicron BA.1 has a lot of mutations (15) in the receptor-binding domain (RBD), of which five have been shown to enhance binding to the ACE2 receptor. This strain also has a lot of mutation in the N-terminal domain (NTD) , 4 mutations, 3 deletions and one insertion (Figure 2).

Diagram showing mutations in the gene encoding the spike protein of the omicron BA.1 variant, compared with the original Wuhan-Hu strain and the position of these mutations.
Figure 2 (a) Mutations in the gene encoding the spike protein of the omicron BA.1 variant, compared with the original Wuhan-Hu strain. (b) The position of these mutations (red dots) on a model of the spike protein shows the cluster of mutations in the receptor-binding domain (RBD) which is shown in yellow.

Many of the neutralising antibodies bind to the RBD and NTD regions of the spike protein, so these mutations have allowed the omicron BA.1 variant to substantially evade the antibody response produced by previous variants. Since different people produce antibodies to different regions of the spike protein, the extent to which new variants evade antibodies produced by earlier strains varies between individuals.